These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE. Bruce CD, Fegely KA, Rajabi-Siahboomi AR, McGinity JW. Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604 [Abstract] [Full Text] [Related]
3. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices. Bruce CD, Fegely KA, Rajabi-Siahboomi AR, McGinity JW. Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992 [Abstract] [Full Text] [Related]
4. The manufacture and characterisation of hot-melt extruded enteric tablets. Andrews GP, Jones DS, Diak OA, McCoy CP, Watts AB, McGinity JW. Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604 [Abstract] [Full Text] [Related]
5. Properties of melt extruded enteric matrix pellets. Schilling SU, Shah NH, Waseem Malick A, McGinity JW. Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133 [Abstract] [Full Text] [Related]
6. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D, Zheng W, Coots LB, McGinity JW. Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [Abstract] [Full Text] [Related]
7. Citric acid as a solid-state plasticizer for Eudragit RS PO. Schilling SU, Shah NH, Malick AW, Infeld MH, McGinity JW. J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259 [Abstract] [Full Text] [Related]
8. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW. Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412 [Abstract] [Full Text] [Related]
9. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion. Bando H, McGinity JW. Int J Pharm; 2006 Oct 12; 323(1-2):11-7. PubMed ID: 16815652 [Abstract] [Full Text] [Related]
11. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Bruce LD, Shah NH, Malick AW, Infeld MH, McGinity JW. Eur J Pharm Biopharm; 2005 Jan 12; 59(1):85-97. PubMed ID: 15567305 [Abstract] [Full Text] [Related]
12. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. Andrews GP, AbuDiak OA, Jones DS. J Pharm Sci; 2010 Mar 12; 99(3):1322-35. PubMed ID: 19798757 [Abstract] [Full Text] [Related]
13. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion. Ozgüney I, Shuwisitkul D, Bodmeier R. Eur J Pharm Biopharm; 2009 Sep 12; 73(1):140-5. PubMed ID: 19406237 [Abstract] [Full Text] [Related]
14. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Albers J, Alles R, Matthée K, Knop K, Nahrup JS, Kleinebudde P. Eur J Pharm Biopharm; 2009 Feb 12; 71(2):387-94. PubMed ID: 18951978 [Abstract] [Full Text] [Related]
15. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms. Zhu Y, Mehta KA, McGinity JW. Pharm Dev Technol; 2006 Feb 12; 11(3):285-94. PubMed ID: 16895839 [Abstract] [Full Text] [Related]
17. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H, Fussnegger B, Bodmeier R. Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875 [Abstract] [Full Text] [Related]